Additionally, a scoring system established on a scale of 5–15 points that was comprised of three stages depending on the methylation values of the five chosen genes [HOXA6, HOXA9, PENK, UPK3A, and IGF2BP1 (39)] also verified the value of methylation in meningiomas. The gene discussed is HOXA9; the disease is meningioma.